scispace - formally typeset
Open AccessJournal ArticleDOI

The ischemic environment drives microglia and macrophage function.

Reads0
Chats0
TLDR
The selective responses of microglia and macrophages to hypoxia after stroke are discussed and relevant markers are reviewed with the aim of defining the different subpopulations of myeloid cells that are recruited to the injured site.
Abstract
Cells of myeloid origin, such as microglia and macrophages, act at the crossroads of several inflammatory mechanisms during pathophysiology. Besides pro-inflammatory activity (M1 polarization), myeloid cells acquire protective functions (M2) and participate in the neuroprotective innate mechanisms after brain injury. Experimental research is making considerable efforts to understand the rules that regulate the balance between toxic and protective brain innate immunity. Environmental changes affect microglia/macrophage functions. Hypoxia can affect myeloid cell distribution, activity, and phenotype. With their intrinsic differences, microglia and macrophages respond differently to hypoxia, the former depending on ATP to activate and the latter switching to anaerobic metabolism and adapting to hypoxia. Myeloid cell functions include homeostasis control, damage-sensing activity, chemotaxis, and phagocytosis, all distinctive features of these cells. Specific markers and morphologies enable to recognize each functional state. To ensure homeostasis and activate when needed, microglia/macrophage physiology is finely tuned. Microglia are controlled by several neuron-derived components, including contact-dependent inhibitory signals and soluble molecules. Changes in this control can cause chronic activation or priming with specific functional consequences. Strategies, such as stem cell treatment, may enhance microglia protective polarization. This review presents data from the literature that has greatly advanced our understanding of myeloid cell action in brain injury. We discuss the selective responses of microglia and macrophages to hypoxia after stroke and review relevant markers with the aim of defining the different subpopulations of myeloid cells that are recruited to the injured site. We also cover the functional consequences of chronically active microglia and review pivotal works on microglia regulation that offer new therapeutic possibilities for acute brain injury.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Microglia in Physiology and Disease

TL;DR: The diversity of microglia phenotypes and their responses in health, aging, and disease are described and treatment options that modulate microglial phenotypes are discussed.
Journal ArticleDOI

Modulators of microglial activation and polarization after intracerebral haemorrhage.

TL;DR: Key studies on modulators of microglial activation and polarization after ICH are summarized, including M1-like and M2-like microglia phenotype markers, transcription factors and key signalling pathways, and the evidence that therapeutic approaches aimed at modulating microglian function might mitigate ICH injury and improve brain repair is presented.
Journal ArticleDOI

Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke

TL;DR: This review summarizes recent progress concerning the mechanisms involved in brain damage, repair and regeneration related to microglia/macrophage activation and phenotype transition after stroke and argues that future translational studies should be targeting multiple key regulating molecules to improve brain repair.
Journal ArticleDOI

The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.

TL;DR: New potential therapeutics need to interfere with these diabetic complications even before changes in the retina are diagnosed, to prevent neuronal apoptosis and blindness in patients.
Journal ArticleDOI

Inflammatory Disequilibrium in Stroke

TL;DR: The frontiers of current knowledge of innate and adaptive immune responses in the brain and how these responses together shape the course of ischemic stroke are explored.
References
More filters
Journal ArticleDOI

Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB

TL;DR: In this paper, the p50 subunit of NF-κB was identified as a key regulator of M2-driven inflammatory reactions in vitro and in vivo, and p50-deficient mice showed exacerbated M1-driven inflammation and defective capacity to mount allergy and helminth-driven M2polarized inflammatory reactions.
Journal ArticleDOI

Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10.

TL;DR: IL-10 and TGF-beta induce different phenotypes of macrophage deactivation, and deactivate macrophages by different mechanisms: IL-10 promotes degradation of cytokine mRNA, while T GF-beta primarily suppresses translation.
Journal ArticleDOI

CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity.

TL;DR: The results reveal that under physiological conditions, disruption in CX3CL1 signaling will lead to impairment in cognitive function and synaptic plasticity via increased action of IL-1β.
Journal ArticleDOI

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47

TL;DR: It is suggested that microRNA dysregulated in multiple sclerosis lesions reduce CD47 in brain resident cells, releasing macrophages from inhibitory control, thereby promoting phagocytosis of myelin and have broad implications for microRNA-regulated macrophage activation in inflammatory diseases.
Journal ArticleDOI

Regulation of tau pathology by the microglial fractalkine receptor

TL;DR: The results suggest that CX3CR1 and IL-1/p38 MAPK may serve as novel therapeutic targets for human tauopathies.
Related Papers (5)